AGUSTONI, FRANCESCO
AGUSTONI, FRANCESCO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors
2015-05-01 D. Serpico, A. Trama, E.R. Haspinger, F. Agustoni, L. Botta, R. Berardi, G. Palmieri, P. Zucali, R. Gallucci, M. Broggini, G. Gatta, U. Pastorino, G. Pelosi, F. De Braud, M.C. Garassino
Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer
2011-01-01 M. Platania, F. Agustoni, B. Formisano, M. Vitali, M. Ducceschi, F. Pietrantonio, N. Zilembo, F. Gelsomino, S. Pusceddu, R. Buzzoni
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer (Front. Oncol., (2021), 11, (744956), 10.3389/fonc.2021.744956)
2021-01-01 A. Bruni, V. Scotti, P. Borghetti, S. Vagge, S. Cozzi, E. D'Angelo, N. Giaj Levra, A. Fozza, M. Taraborrelli, G. Piperno, V. Vanoni, M. Sepulcri, M. Trovo, V. Nardone, E. Lattanzi, S. Bou Selman, F. Bertolini, D. Franceschini, F. Agustoni, B.A. Jereczek-Fossa, S.M. Magrini, L. Livi, F. Lohr, A.R. Filippi
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non–small-cell Lung Cancer (NSCLC) : An Italian, Multicenter, Retrospective Study
2020-05-13 A. Luciani, A. Marra, L. Toschi, D. Cortinovis, S. Fava, V. Filipazzi, A. Tuzi, G. Cerea, S. Rossi, V. Perfetti, A. Rossi, L. Giannetta, L. Sala, G. Finocchiaro, E.G. Pizzutilo, S. Carelli, F. Agustoni, M. Cergnul, S. Zonato, S. Siena, P. Bidoli, D. Ferrari
Emerging toxicities in the treatment of non-small cell lung cancer : ocular disorders
2014-02-01 F. Agustoni, M. Platania, M. Vitali, N. Zilembo, E. Haspinger, V. Sinno, R. Gallucci, F. De Braud, M.C. Garassino
Fatal case of hepatic portal venous gas following palliative stenting and chemotherapy for occlusive advanced colorectal cancer
2015-03-01 M. Platania, B. Valeri, A. Marchianò, G. Calareso, F. Agustoni, E. Haspinger, S. Pusceddu, M.C. Garassino, F. Gelsomino, F. de Braud
Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? : Analysis of a phase II trial
2013-01-01 S. Damian, L. Celio, E. De Benedictis, P. Mariani, F. Agustoni, F. Ricchini, F. De Braud
A real-world, multicenter, observational retrospective study of durvalumab after concomitant or sequential chemoradiation for unresectable stage III non-small cell lung cancer
2021-09-28 A. Bruni, V. Scotti, P. Borghetti, S. Vagge, S. Cozzi, E. D'Angelo, N. Giaj Levra, A. Fozza, M. Taraborrelli, G. Piperno, V. Vanoni, M. Sepulcri, M. Trovo, V. Nardone, E. Lattanzi, S. Bou Selman, F. Bertolini, D. Franceschini, F. Agustoni, B.A. Jereczek-Fossa, S.M. Magrini, L. Livi, F. Lohr, A.R. Filippi
Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
2016-02-04 D. Signorelli, M. Macerelli, C. Proto, M. Vitali, M.S. Cona, F. Agustoni, N. Zilembo, M. Platania, A. Trama, R. Gallucci, M. Ganzinelli, G. Pelosi, U. Pastorino, F. De Braud, M.C. Garassino, G. Lo Russo